Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 506 entries
View as:

Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia

Phase: N/A Priority: Normal
NCT ID: NCT01189279 Org: User:
Start: 10/31/10 End: 02/28/11 Due: 02/28/12

Study of the Safety and Effectiveness of JUVÉDERM VOLUX™ XC Injectable Gel for Restoring Jawline Definition

Phase: N/A Priority: Normal
NCT ID: NCT03712137 Org: User:
Start: 11/12/18 End: 01/26/21 Due: 01/26/22

Safety and Efficacy of Tazarotene Cream 0.1% Compared With Adapalene Gel 0.3% in the Treatment of Moderate to Severe Facial Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT00829049 Org: User:
Start: 10/31/07 End: 10/31/08 Due: 10/31/09

BOTOX® (onabotulinumtoxinA) Treatment of Masseter Muscle Prominence

Phase: N/A Priority: Normal
NCT ID: NCT03861936 Org: User:
Start: 05/16/19 End: 07/02/20 Due: 07/02/21

Safety and Patient Satisfaction With GLASH VISTA™ (Bimatoprost 0.03%) in the Treatment of Eyelash Hypotrichosis in Japan

Phase: N/A Priority: Normal
NCT ID: NCT02505776 Org: User:
Start: 12/08/14 End: 05/21/18 Due: 05/21/19

Efficacy and Safety Study of BOTOX® Compared to Topiramate for the Prevention of Chronic Migraine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT02191579 Org: User:
Start: 08/05/14 End: 09/01/17 Due: 09/01/18

A Study to Evaluate the Effect of Juvederm Volift With Lidocaine on Aging Hands in Participants Age 35 and Older

Phase: N/A Priority: Normal
NCT ID: NCT04390581 Org: User:
Start: 05/20/20 End: 12/06/22 Due: 12/06/23

A Retrospective Chart Review to Evaluate Diagnosis and Treatment of Chronic Migraine and Headache

Phase: N/A Priority: Normal
NCT ID: NCT01946126 Org: User:
Start: 03/31/14 End: 04/30/14 Due: 04/30/15

Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Phase: N/A Priority: Normal
NCT ID: NCT03233438 Org: User:
Start: 07/24/17 End: 10/30/18 Due: 10/30/19

A Study Using Botulinum Toxin Type A in Adolescents With Axillary Hyperhidrosis

Phase: N/A Priority: Normal
NCT ID: NCT00168415 Org: User:
Start: 08/31/05 End: 06/30/07 Due: 06/30/08

International CoolSculpting: Study to Evaluate Patient Satisfaction for Non-Invasive Fat Reduction in Abdomen and/or Flanks (iCOOL)

Phase: N/A Priority: Normal
NCT ID: NCT03909100 Org: User:
Start: 07/29/19 End: 02/28/20 Due: 02/28/21

AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis

Phase: N/A Priority: Normal
NCT ID: NCT02161146 Org: User:
Start: 06/04/14 End: 12/20/14 Due: 12/20/15

Evaluation of Age-related Skin Changes Using Clinical Probe Measurements and Imaging Modalities in Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04655300 Org: User:
Start: 01/16/21 End: 02/05/21 Due: 02/05/22

Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine

Phase: N/A Priority: Normal
NCT ID: NCT03855137 Org: User:
Start: 03/11/19 End: 01/20/22 Due: 01/20/23

Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01110499 Org: User:
Start: 06/30/10 End: 06/30/11 Due: 06/30/12

A Safety and Efficacy Study of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korean Patients

Phase: N/A Priority: Normal
NCT ID: NCT02601287 Org: User:
Start: 11/30/15 End: 07/31/16 Due: 07/31/17

Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease

Phase: N/A Priority: Normal
NCT ID: NCT04393441 Org: User:
Start: 06/29/20 End: 06/15/21 Due: 06/15/22

Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01284166 Org: User:
Start: 07/31/13 End: 05/31/14 Due: 05/31/15

A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides

Phase: N/A Priority: Normal
NCT ID: NCT02261493 Org: User:
Start: 10/27/14 End: 04/20/16 Due: 04/20/17

Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine

Phase: N/A Priority: Normal
NCT ID: NCT02828020 Org: User:
Start: 07/22/16 End: 12/14/17 Due: 12/14/18

Evaluation of Maintaining Visual Performance in Participants Who Engage in Electronic Visual Tasking While Using Restasis®

Phase: N/A Priority: Normal
NCT ID: NCT02554981 Org: User:
Start: 07/21/15 End: 03/24/16 Due: 03/24/17

A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01863953 Org: User:
Start: 06/30/13 End: 12/31/13 Due: 12/31/14

Clinical Trial To Evaluate ANT-1207 In Participants With Primary Axillary Hyperhidrosis

Phase: N/A Priority: Normal
NCT ID: NCT02479139 Org: User:
Start: 06/03/15 End: 02/29/16 Due: 02/28/17

Performance and Acceptance of Optive Versus Hylocomod Eyedrops in Patients With Dry Eye Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT00761202 Org: User:
Start: 08/31/07 End: 06/30/08 Due: 06/30/09

An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Switched IOP-lowering Treatments

Phase: N/A Priority: Normal
NCT ID: NCT01735214 Org: User:
Start: 03/07/13 End: 04/10/14 Due: 04/10/15